Cost-Utility Analyses in Diabetes: A Systematic Review and Implications from Real-World Evidence

Most diabetes interventions evaluated by CUAs are recommended by practice guidelines and may provide good value for money. Our results indicate that patients with diabetes and the health care system could potentially benefit from shifting to the greater use of high-value services.